Pathak et al. (2016), PeerJ, DOI 10.7717/peerj.1738; 1-14
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Miscellaneous
Chapter J.3
Strengthening Parmaceutical Systems. 2nd edition
braz j infect dis. 2014;18(5):491–495
http://dx.doi.org/10.1016/j.bjid.2014.02.004
1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
Sunsari Technical College Journal Oktober 2012
A global Review of evidence and practice
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...ions caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
more
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017